Package 45802-351-65

{"route": ["ORAL"], "spl_id": "11c471e0-6c64-4f13-b6ed-d2c80bc89f20", "openfda": {"upc": ["0345802260659", "0345802402653", "0345802351654", "0345802499653"], "unii": ["JQT35NPK6C", "EEN99869SC"], "rxcui": ["1368410", "1368424", "1368431", "1368438"], "spl_set_id": ["642b1e90-701e-42f2-bac6-a4918738e2c9"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (45802-351-65)", "package_ndc": "45802-351-65", "marketing_start_date": "20160408"}], "brand_name": "Alogliptin and Pioglitazone", "product_id": "45802-351_11c471e0-6c64-4f13-b6ed-d2c80bc89f20", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Dipeptidyl Peptidase 4 Inhibitor [EPC]", "Dipeptidyl Peptidase 4 Inhibitors [MoA]", "Peroxisome Proliferator Receptor alpha Agonist [EPC]", "Peroxisome Proliferator Receptor gamma Agonist [EPC]", "Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]", "Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]", "Thiazolidinedione [EPC]", "Thiazolidinediones [CS]"], "product_ndc": "45802-351", "generic_name": "Alogliptin Benzoate and Pioglitazone hydrochloride", "labeler_name": "Padagis Israel Pharmaceuticals Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Alogliptin and Pioglitazone", "active_ingredients": [{"name": "ALOGLIPTIN BENZOATE", "strength": "25 mg/1"}, {"name": "PIOGLITAZONE HYDROCHLORIDE", "strength": "15 mg/1"}], "application_number": "NDA022426", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20160408", "listing_expiration_date": "20261231"}